Sarah Siber

Ms. Siber is a Principal at Oberland Capital. Prior to joining Oberland Capital, Ms. Siber was a Senior Manager in Corporate Development at Pfizer where she was responsible for evaluating and supporting the execution of the company’s strategic transactions, including M&A, licensing deals, and corporate-level divestitures. Previously, Ms. Siber was an Investment Operations Analyst at Blackstone Alternative Asset Management and an Investment Banking Analyst in the healthcare group at Oppenheimer & Co. Ms. Siber earned her M.B.A. from Columbia Business School and her B.S. in Operations Research & Information Engineering from Cornell University.